QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 151 filers reported holding QIAGEN NV in Q3 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,043,000 | +61.6% | 72,909 | +58.3% | 0.00% | 0.0% |
Q3 2016 | $1,264,000 | +25.8% | 46,071 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $1,005,000 | -2.3% | 46,071 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $1,029,000 | -17.6% | 46,071 | +2.0% | 0.00% | 0.0% |
Q4 2015 | $1,249,000 | +7.2% | 45,165 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $1,165,000 | +4.0% | 45,165 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $1,120,000 | +25.3% | 45,165 | +27.4% | 0.00% | 0.0% |
Q1 2015 | $894,000 | +56.6% | 35,459 | +45.6% | 0.00% | – |
Q4 2014 | $571,000 | +2.9% | 24,359 | 0.0% | 0.00% | – |
Q3 2014 | $555,000 | -6.9% | 24,359 | 0.0% | 0.00% | – |
Q2 2014 | $596,000 | +16.0% | 24,359 | 0.0% | 0.00% | – |
Q1 2014 | $514,000 | -33.9% | 24,359 | -25.5% | 0.00% | -100.0% |
Q4 2013 | $778,000 | +69.5% | 32,683 | +52.3% | 0.00% | – |
Q3 2013 | $459,000 | +24.7% | 21,453 | +15.9% | 0.00% | – |
Q2 2013 | $368,000 | – | 18,508 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |